|
Market Closed -
Nasdaq Stockholm
17:00:00 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 5.190 SEK | +1.37% |
|
-4.77% | -7.32% |
| 10-05 | Mendus appoints board member chief operating officer | FW |
| 10-05 | Mendus AB Announces Management Changes, Effective October 05, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 34.79M | - | ||||
| 66.22B | |||||
| 55.2B | |||||
| 52.79B | |||||
| 45.53B | |||||
| 43.94B |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
